DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 3.30% to $9.07 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.66% to 26,040.03 and Dow Jones Industrial Average falling 0.03% to 52,305.24.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 55.89% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.14% to $6.05, Fortress Biotech Inc. (FBIO) rose 0.98% to $3.09, and Viking Therapeutics Inc. (VKTX) fell 3.92% to $37.48.
Data source: Dow Jones Market Data, FactSet. Data compiled July 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 01, 2026 17:19 ET (21:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments